Jamie Lesnock

1.7k total citations · 1 hit paper
52 papers, 1.2k citations indexed

About

Jamie Lesnock is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Jamie Lesnock has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Reproductive Medicine, 23 papers in Obstetrics and Gynecology and 13 papers in Surgery. Recurrent topics in Jamie Lesnock's work include Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Cervical Cancer and HPV Research (9 papers). Jamie Lesnock is often cited by papers focused on Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Cervical Cancer and HPV Research (9 papers). Jamie Lesnock collaborates with scholars based in United States, Netherlands and United Kingdom. Jamie Lesnock's co-authors include Robert P. Edwards, Nataša Obermajer, Paweł Kaliński, Ravikumar Muthuswamy, Thomas C. Krivak, Sushil Beriwal, Paniti Sukumvanich, Robin Laskey, Jeff Lin and Malcolm S. Ross and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Jamie Lesnock

44 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update

2025 15 citations Stéphanie Gaillard, Christina Lacchetti et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jamie Lesnock United States	16	382	338	332	317	292	52	1.2k
Jeff Lin United States	15	441 1.2×	184 0.5×	293 0.9×	173 0.5×	321 1.1×	36	1.2k
Corinne Doll Canada	20	355 0.9×	81 0.2×	401 1.2×	133 0.4×	388 1.3×	70	1.1k
Robin Laskey United States	7	301 0.8×	80 0.2×	156 0.5×	223 0.7×	160 0.5×	9	679
Larissa J. Lee United States	24	857 2.2×	63 0.2×	344 1.0×	506 1.6×	461 1.6×	70	1.7k
Katrien Vandecasteele Belgium	19	165 0.4×	154 0.5×	290 0.9×	96 0.3×	211 0.7×	57	1.1k
Vanda Salutari Italy	23	412 1.1×	179 0.5×	555 1.7×	722 2.3×	291 1.0×	110	1.5k
Jacob Korach Israel	24	565 1.5×	134 0.4×	567 1.7×	886 2.8×	222 0.8×	107	1.6k
Mika Mizuno Japan	23	488 1.3×	95 0.3×	275 0.8×	612 1.9×	225 0.8×	77	1.2k
Antonio Febbraro Italy	18	70 0.2×	110 0.3×	649 2.0×	174 0.5×	253 0.9×	56	1.2k
Ming-Shian Kao United States	19	869 2.3×	68 0.2×	153 0.5×	535 1.7×	483 1.7×	36	1.3k

Countries citing papers authored by Jamie Lesnock

Since Specialization

Citations

This map shows the geographic impact of Jamie Lesnock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamie Lesnock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamie Lesnock more than expected).

Fields of papers citing papers by Jamie Lesnock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamie Lesnock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamie Lesnock. The network helps show where Jamie Lesnock may publish in the future.

Co-authorship network of co-authors of Jamie Lesnock

This figure shows the co-authorship network connecting the top 25 collaborators of Jamie Lesnock. A scholar is included among the top collaborators of Jamie Lesnock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamie Lesnock. Jamie Lesnock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gaillard, Stéphanie, Christina Lacchetti, Deborah K. Armstrong, et al.. (2025). Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update. Obstetrical & Gynecological Survey. 80(7). 421–422.

Gaillard, Stéphanie, Christina Lacchetti, Deborah K. Armstrong, et al.. (2025). Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 43(7). 868–891. 15 indexed citations breakdown →

Soong, T. Rinda, et al.. (2024). Clinical outcomes following identification of an incidental p53 signature in the fallopian tube. Gynecologic Oncology Reports. 52. 101359–101359. 2 indexed citations

Bell, Sarah, et al.. (2023). Prophylactic anticoagulation after minimally invasive hysterectomy for endometrial cancer: a cost-effectiveness analysis. International Journal of Gynecological Cancer. 33(12). 1875–1881. 2 indexed citations

Lesnock, Jamie, et al.. (2023). Use of indocyanine green dye for sentinel lymph node mapping in patients with endometrial cancer and a history of iodinated contrast allergy (176). Gynecologic Oncology. 176. S68–S68. 2 indexed citations

Sukumvanich, Paniti, Madeleine Courtney‐Brooks, Jessica Berger, et al.. (2023). The role of obesity in treatment planning for early-stage cervical cancer. Gynecologic Oncology. 181. 60–67. 1 indexed citations

Kim, Hayeon, et al.. (2023). Cost-effectiveness analysis of tumor molecular testing in stage III endometrial cancer. Gynecologic Oncology. 173. 81–87. 9 indexed citations

Lang, Susan M., et al.. (2023). Feasibility of intraoperative injection of radioactive tracer and blue dye for sentinel lymph node biopsy in vulvar cancer. Gynecologic Oncology. 175. 41–44. 2 indexed citations

Coffman, Lan, Leonard Frisbie, Daniel P. Normolle, et al.. (2022). Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer. JCI Insight. 7(18). 13 indexed citations

10.

Korentzelos, Dimitrios, Esther Elishaev, Chengquan Zhao, et al.. (2022). ARID1A, BRG1, and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma: a clinicopathologic, immunohistochemical, and next-generation sequencing analysis of a case series from a single institution. Human Pathology. 130. 65–78. 3 indexed citations

11.

Beriwal, Sushil, Rohit Bhargava, J. Berger, et al.. (2021). Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer. Gynecologic Oncology. 164(1). 129–135. 17 indexed citations

12.

Patel, Ankur, Andrew Keller, John A. Vargo, et al.. (2020). Do air gaps with image-guided vaginal cuff brachytherapy impact failure rates in patients with high-intermediate risk FIGO Stage I endometrial cancer?. Brachytherapy. 20(3). 512–518. 2 indexed citations

13.

Lesnock, Jamie, et al.. (2015). Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced-stage ovarian cancer in patients 65 years old or older. American Journal of Obstetrics and Gynecology. 212(6). 763.e1–763.e8. 23 indexed citations

14.

Lesnock, Jamie, Robert M. Arnold, Leslie A. Meyn, et al.. (2013). Palliative care education in gynecologic oncology: A survey of the fellows. Gynecologic Oncology. 130(3). 431–435. 34 indexed citations

15.

Lesnock, Jamie, Coreen Farris, Thomas C. Krivak, Kenneth J. Smith, & Maurie Markman. (2011). Consolidation paclitaxel is more cost-effective than bevacizumab following upfront treatment of advanced epithelial ovarian cancer. Gynecologic Oncology. 122(3). 473–478. 28 indexed citations

16.

Skaznik-Wikiel, Malgorzata E., Jamie Lesnock, Sushil Beriwal, et al.. (2011). Intraperitoneal Chemotherapy for Recurrent Epithelial Ovarian Cancer Is Feasible With High Completion Rates, Low Complications, and Acceptable Patient Outcomes. International Journal of Gynecological Cancer. 22(2). 232–237. 10 indexed citations

17.

Fader, Amanda N., et al.. (2010). Cervical dysplasia in pregnancy: a multi-institutional evaluation. American Journal of Obstetrics and Gynecology. 203(2). 113.e1–113.e6. 42 indexed citations

18.

Richard, Scott D., Paniti Sukumvanich, Jamie Lesnock, et al.. (2010). Intraperitoneal Catheter Leads to Prolongation of the Time to Normalization of Serum CA125 Levels. International Journal of Gynecological Cancer. 20(6). 932–935. 3 indexed citations

19.

Lesnock, Jamie, Scott D. Richard, Kristin K. Zorn, et al.. (2009). Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications. Gynecologic Oncology. 116(3). 345–350. 25 indexed citations

20.

McIntyre‐Seltman, Kathleen & Jamie Lesnock. (2008). Cervical Cancer Screening in Pregnancy. Obstetrics and Gynecology Clinics of North America. 35(4). 645–658. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact